| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VIRUSRES.2015.04.005 |
| P698 | PubMed publication ID | 25892718 |
| P2093 | author name string | Kuk Jin Park | |
| Soo In Kim | |||
| Dong Ho Ahn | |||
| Eun Young Cho | |||
| Mi Suk Kim | |||
| Duckhyang Shin | |||
| Hyeon Lee | |||
| Mi Hui Hwang | |||
| P2860 | cites work | Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly | Q21560857 |
| Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance | Q28728106 | ||
| Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial | Q30226730 | ||
| A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. | Q30369945 | ||
| HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. | Q30374103 | ||
| Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs | Q30391377 | ||
| Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion | Q30409570 | ||
| Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems | Q30517014 | ||
| Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs. | Q33782919 | ||
| Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults | Q34498228 | ||
| Molecular studies of influenza B virus in the reverse genetics era. | Q37798373 | ||
| Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation | Q39422643 | ||
| A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. | Q39678999 | ||
| PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice | Q40579478 | ||
| Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children | Q40755954 | ||
| Humoral and cell-mediated immunity to vero cell-derived influenza vaccine | Q40834749 | ||
| Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses | Q40948522 | ||
| Development of a mammalian cell (Vero) derived candidate influenza virus vaccine | Q41021315 | ||
| Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs | Q44077186 | ||
| Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture | Q45771833 | ||
| The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analyses | Q45774432 | ||
| Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual | Q45831920 | ||
| Universal primer set for the full-length amplification of all influenza A viruses | Q57202943 | ||
| Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule | Q69645414 | ||
| Host cell-mediated variation in H3N2 influenza viruses | Q69738807 | ||
| P304 | page(s) | 40-46 | |
| P577 | publication date | 2015-04-17 | |
| P1433 | published in | Virus Research | Q15749215 |
| P1476 | title | Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines | |
| P478 | volume | 204 |
| Q89969421 | Development and characterization of standard reagents for cell-based prepandemic influenza vaccine products |
| Q98578103 | Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine |
| Q92564449 | Evaluation of novel disposable bioreactors on pandemic influenza virus production |
| Q59359988 | Preparation and protective efficacy of a chicken embryo kidney cell-attenuation GI-19/QX-like avian infectious bronchitis virus vaccine |
| Q40132244 | Suspension culture process for H9N2 avian influenza virus (strain Re-2). |
| Q41925928 | The hUC-MSCs cell line CCRC-1 represents a novel, safe and high-yielding HDCs for the production of human viral vaccines |
| Q55447639 | The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. |
Search more.